[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100331853":3},{"organization":4,"outcomesModule":7,"designInfo":45,"detailedDescription":18,"studyPopulation":18,"armGroups":51,"interventions":63,"overallOfficials":69,"centralContacts":74,"locations":80,"responsibleParty":97,"collaborators":99,"id":102,"slug":18,"hasResults":103,"nctId":104,"briefTitle":105,"officialTitle":106,"acronym":53,"eligibilityCriteria":107,"healthyVolunteers":103,"sex":108,"minAge":109,"maxAge":18,"enrollmentInfo":110,"targetDuration":18,"studyType":113,"phases":114,"briefSummary":116,"conditions":117,"keywords":119,"overallStatus":82,"whyStopped":18,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":133},{"fullName":5,"class":6},"Deutsches Herzzentrum Muenchen","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":18},[9],{"measure":10,"description":11,"timeFrame":12},"Effective orifice area","Effective orifice area in cm2 (EOA) either after the TriRec- procedure or surgical valve replacement with the St. Jude Medical Trifecta GT Valve, measured by echocardiography","10th postoperative day +\u002F- 4 days",[14,16,20,23,25,27,29,31,33,35,37,39,41,43],{"measure":10,"description":11,"timeFrame":15},"after 6 months, 1 year and thereafter annually until the 10th postoperative year",{"measure":17,"description":18,"timeFrame":19},"Maximum and mean aortic pressure gradients",null,"10th postoperative day +\u002F- 4 days, after 6 months, 1 year and thereafter annually until the 10th postoperative year.",{"measure":21,"description":18,"timeFrame":22},"Estimation of aortic regurgitation, if applicable","10th postoperative day +\u002F- 4 days, after 6 months, 1 year and thereafter annually until the 10th postoperative year",{"measure":24,"description":18,"timeFrame":22},"Left ventricular ejection fraction",{"measure":26,"description":18,"timeFrame":22},"Left ventricular endsystolic and -diastolic diameter",{"measure":28,"description":18,"timeFrame":22},"Left ventricular endsystolic and -diastolic volume",{"measure":30,"description":18,"timeFrame":22},"Left atrial diameter",{"measure":32,"description":18,"timeFrame":22},"Freedom from aortic valve reintervention at discharge",{"measure":34,"description":18,"timeFrame":19},"Freedom from Mortality",{"measure":36,"description":18,"timeFrame":19},"Freedom from Stroke",{"measure":38,"description":18,"timeFrame":19},"Freedom from Myocardial infarction",{"measure":40,"description":18,"timeFrame":19},"Freedom from conduction disturbances leading to permanent pacemaker implantation",{"measure":42,"description":18,"timeFrame":19},"Freedom from Endocarditis",{"measure":44,"description":18,"timeFrame":19},"Freedom from Bleeding requiring re-thoracotomy",{"allocation":46,"interventionModel":47,"interventionModelDescription":18,"primaryPurpose":48,"observationalModel":18,"timePerspective":18,"maskingInfo":49},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":50,"maskingDescription":18,"whoMasked":18},"NONE",[52,58],{"label":53,"type":54,"description":55,"interventionNames":56},"TriRec","EXPERIMENTAL","Trileaflet Reconstruction of the Aortic Valve",[57],"Other: TriRec",{"label":59,"type":54,"description":60,"interventionNames":61},"Aortic valve replacement","Biological prosthesis, Device: St. Jude Medical Trifecta GT",[62],"Other: Aortic valve replacement",[64,66],{"type":6,"name":53,"description":55,"armGroupLabels":65,"otherNames":18},[53],{"type":6,"name":59,"description":67,"armGroupLabels":68,"otherNames":18},"Biological Prosthesis, Device: St. Jude Medical Trifecta GT",[59],[70],{"name":71,"affiliation":72,"role":73},"Markus Krane, MD, PhD","Department of Cardiovascular Surgery, German Heart Center Munich","STUDY_CHAIR",[75],{"name":71,"role":76,"phone":77,"phoneExt":78,"email":79},"CONTACT","+4989-1218","4111","krane@dhm.mhn.de",[81],{"facility":72,"status":82,"city":83,"state":84,"zip":85,"country":86,"countryCode":87,"cosmosGeoPoint":88,"geoPoint":93,"contacts":94},"RECRUITING","Munich","Bavaria","80336","Germany","DE",{"type":89,"coordinates":90},"Point",[91,92],11.57549,48.13743,{"lat":92,"lon":91},[95],{"name":71,"role":76,"phone":77,"phoneExt":96,"email":79},"-4111",{"type":98,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[100],{"name":72,"class":101},"UNKNOWN","100331853",false,"NCT03600662","TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium","TriRec - Trileaflet Reconstruction of the Aortic Valve","Inclusion Criteria:\n\n* Age \\>= 50 years\n* Documented symptomatic moderate or greater aortic stenosis or severe insufficiency\n* Aortic annulus \\> 19 mm\n* Written informed consent of the patient.\n\nExclusion Criteria:\n\n* Concomitant intervention of the aortic root\n* Concomitant intervention of the aortic arch\n* Concomitant valve surgery\n* Emergency surgery for any reason\n* Neurological events (i.e. stroke, TIA) within 6 months preoperatively\n* Coagulation disorders (including thrombocytopenia \\\u003C 100.000\u002Fml)\n* Porcelain aorta\n* Active endocarditis or other active systemic infections\n* Participating in another trial that may influence the outcome of this trial\n* Pregnancy\n* Dual antiplatelet therapy\n* Previous cardiac surgery (excluding percutaneous procedures)","ALL","50 Years",{"count":111,"type":112},128,"ESTIMATED","INTERVENTIONAL",[115],"NA","Reconstruction of the aortic valve using the tri-leaflet repair technique is non-inferior with regard to effective orifice area (EOA) to surgical aortic valve replacement (SAVR) with a biological prosthesis (St. Jude Trifecta GT) as gold- standard.",[118],"Alternative Surgical Treatment for Aortic Valve Disease",[120,121,122,123,10],"aortic stenosis","aortic regurgitation","Trileaflet reconstruction of the aortic valve","Biological aortic valve prosthesis","2018-07-16",{"date":126,"type":127},"2018-07-26","ACTUAL",{"date":129,"type":127},"2018-01-18",{"date":131,"type":112},"2030-01",{"name":5,"class":6},1]